Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€705.50
07.08.23
07.08.23
€817.83
07.08.24
07.08.24
37.94%
08.08.24
08.08.24
Community Health Systems Inc.
Start price
Target price
Perf. (%)
€3.76
07.08.23
07.08.23
€5.91
07.08.24
07.08.24
13.30%
08.08.24
08.08.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.00
07.08.23
07.08.23
€66.34
07.08.24
07.08.24
-15.88%
08.08.24
08.08.24
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
07.08.23
07.08.23
-
07.08.24
07.08.24
224.18%
19.01.24
19.01.24
Probably not worthwhile Investment
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€364.80
07.08.23
07.08.23
€477.33
07.08.24
07.08.24
-20.83%
08.08.24
08.08.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€119.50
07.08.23
07.08.23
€205.48
07.08.24
07.08.24
-14.98%
08.08.24
08.08.24
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.30
07.08.23
07.08.23
€4.55
07.08.24
07.08.24
25.38%
08.08.24
08.08.24
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€166.80
07.08.23
07.08.23
€368.23
07.08.24
07.08.24
41.37%
08.08.24
08.08.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.80
07.08.23
07.08.23
€63.64
07.08.24
07.08.24
-57.02%
08.08.24
08.08.24
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.08
07.08.23
07.08.23
-
07.08.24
07.08.24
-1.10%
19.08.23
19.08.23
Risky Investment
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
07.08.23
07.08.23
-
07.08.24
07.08.24
-27.27%
19.08.23
19.08.23
Could be worthwhile Investment >10% per year
Amneal Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.72
07.08.23
07.08.23
-
07.08.24
07.08.24
69.35%
07.08.24
07.08.24
Risky Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies